Novimmune Novimmune is a company that focuses on its bispecific technology to build a pipeline of multispecific antibodies under the brand Light Chain Bioscience. | ![]() Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases. | Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | |
Founding Date | Founding Date 1998 | Founding Date 2013 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Plan-les-Ouates, CH HQ | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | |
Employees | Employees 80 | Employees 713 | Employees 14,858 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €157.9m (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods €8.2m (FY, 2025) | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit €177.7m (FY, 2025) | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income N/A | Net income (€115.2m) (FY, 2025) | Net income ₹6.7b (FY, 2026) |
Funding | |||
Total funding raised | Total funding raised $ 239.1m | Total funding raised $ 51.7m | Total funding raised N/A |

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.
View companyAlembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company